CpG island methylator phenotype classification improves risk assessment in pediatric T-cell Acute Lymphoblastic Leukemia. Schafer Hackenhaar F, Refhagen N, Hagleitner MM, van Leeuwen FN, et al. Blood 2025 Jan 22:blood.2024026027. doi: 10.1182/blood.2024026027.

Read + Share

Amedeo Smart

Independent Medical Education

Schafer Hackenhaar F, Refhagen N, Hagleitner MM, van Leeuwen FN, et al. CpG island methylator phenotype classification improves risk assessment in pediatric T-cell Acute Lymphoblastic Leukemia. Blood 2025 Jan 22:blood.2024026027. doi: 10.1182/blood.2024026027.
PMID: 39841000